{"disease":{"id":"dka","name":"dka"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05402579","title":"Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk","phase":"","overall_status":"COMPLETED","enrollment_count":63,"lead_sponsor_name":"Mount Sinai Hospital, Canada","has_results":false},{"nct_id":"NCT06007508","title":"Early Administration of Insulin Glargine in Patients With Diabetic Ketoacidosis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":8,"lead_sponsor_name":"HealthPartners Institute","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}